SCP.WA
Price:
$145.6
Market Cap:
$396.90M
Scope Fluidics S.A., a biotechnology company, engages in the designing and developing projects based on microfluidic technologies in medical diagnostics and healthcare. It offers BacterOMIC, an antibiotic susceptibility testing. The company was founded in 2010 and is based in Warsaw, Poland.
Industry
Medical - Diagnostics & Research
IPO Date
2017-08-01
Stock Exchange
WSE
Ticker
SCP.WA
According to Scope Fluidics S.A.’s latest financial reports and current stock price. The company's current ROE is 50.53%. This represents a change of 517.03% compared to the average of 8.19% of the last 4 quarters.
The mean historical ROE of Scope Fluidics S.A. over the last ten years is -10.99%. The current 50.53% ROE has changed -559.79% with respect to the historical average. Over the past ten years (40 quarters), SCP.WA's ROE was at its highest in in the September 2022 quarter at 100.20%. The ROE was at its lowest in in the March 2022 quarter at -77.36%.
Average
-10.99%
Median
-27.98%
Minimum
-63.11%
Maximum
95.65%
Discovering the peaks and valleys of Scope Fluidics S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 563.24%
Maximum Annual ROE = 95.65%
Minimum Annual Increase = -375.37%
Minimum Annual ROE = -63.11%
| Year | ROE | Change |
|---|---|---|
| 2024 | 44.70% | -292.58% |
| 2023 | -23.21% | -124.27% |
| 2022 | 95.65% | -375.37% |
| 2021 | -34.73% | 8.89% |
| 2020 | -31.90% | 2.10% |
| 2019 | -31.24% | -1.78% |
| 2018 | -31.81% | 28.66% |
| 2017 | -24.72% | -60.83% |
| 2016 | -63.11% | 563.24% |
The current ROE of Scope Fluidics S.A. (SCP.WA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
39.05%
5-year avg
10.10%
10-year avg
-10.99%
Scope Fluidics S.A.’s ROE is less than Mercator Medical S.A. (2.69%), less than Centrum Medyczne ENEL-MED S.A. (8.97%), greater than Bioceltix S.A. (-36.36%), greater than Selvita S.A. (0.15%), greater than Ryvu Therapeutics S.A. (-89.88%), greater than Medicalgorithmics S.A. (-20.71%), greater than Bioton S.a. (-1.76%), less than Synthaverse S.A. (6.31%), greater than Captor Therapeutics Spolka Akcyjna (-77.21%), less than BioMaxima S.A. (1.49%),
| Company | ROE | Market cap |
|---|---|---|
| 2.69% | $352.99M | |
| 8.97% | $497.73M | |
| -36.36% | $427.43M | |
| 0.15% | $849.86M | |
| -89.88% | $695.91M | |
| -20.71% | $344.37M | |
| -1.76% | $343.46M | |
| 6.31% | $271.04M | |
| -77.21% | $382.56M | |
| 1.49% | $48.85M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Scope Fluidics S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Scope Fluidics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Scope Fluidics S.A.'s ROE?
How is the ROE calculated for Scope Fluidics S.A. (SCP.WA)?
What is the highest ROE for Scope Fluidics S.A. (SCP.WA)?
What is the 3-year average ROE for Scope Fluidics S.A. (SCP.WA)?
What is the 5-year average ROE for Scope Fluidics S.A. (SCP.WA)?
How does the current ROE for Scope Fluidics S.A. (SCP.WA) compare to its historical average?